J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, C. J.
Right arrow Articles by Taylor-Robinson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, C. J.
Right arrow Articles by Taylor-Robinson, D.
Agricola
Right arrow Articles by Howard, C. J.
Right arrow Articles by Taylor-Robinson, D.

The Journal of Medical Microbiology, Vol 8, Issue 4 523-529, Copyright © 1975 by Society for General Microbiology

JOURNAL ARTICLE

Production of mastitis in mice with human and bovine ureaplasmas (T-mycoplasmas)

C. J. Howard, J. C. Anderson, R. N. Gourlay and D. Taylor-Robinson

Five ureaplasmas (T-mycoplasmas) of human origin and four of bovine origin were inoculated into the mammary glands of mice. The strains multiplied and neutrophils were observed in sections of infected glands. Some of the glands were macroscopically inflamed, albeit slightly, at necropsy but none of the mice showed any sign of disease during the course of the experiments. All nine ureaplasma strains produced mastitis in BSVS mice and the mammary glands of mice appear more susceptible to ureaplasmas than the udders of cows or goats. Mouse mastitis is suggested as being a suitable small animal model for studying ureaplasma infections.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
A. Luhrmann, U. Deiters, J. Skokowa, M. Hanke, J. E. Gessner, P. F. Muhlradt, R. Pabst, and T. Tschernig
In Vivo Effects of a Synthetic 2-Kilodalton Macrophage-Activating Lipopeptide of Mycoplasma fermentans after Pulmonary Application
Infect. Immun., July 1, 2002; 70(7): 3785 - 3792.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Piec, J. Mirkovitch, S. Palacio, P. F. Muhlradt, and R. Felix
Effect of MALP-2, a Lipopeptide from Mycoplasma fermentans, on Bone Resorption In Vitro
Infect. Immun., December 1, 1999; 67(12): 6281 - 6285.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Kaufmann, P. F. Muhlradt, D. Gemsa, and H. Sprenger
Induction of Cytokines and Chemokines in Human Monocytes by Mycoplasma fermentans-Derived Lipoprotein MALP-2
Infect. Immun., December 1, 1999; 67(12): 6303 - 6308.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
U. Deiters and P. F. Muhlradt
Mycoplasmal Lipopeptide MALP-2 Induces the Chemoattractant Proteins Macrophage Inflammatory Protein 1alpha (MIP-1alpha ), Monocyte Chemoattractant Protein 1, and MIP-2 and Promotes Leukocyte Infiltration in Mice
Infect. Immun., July 1, 1999; 67(7): 3390 - 3398.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1975 Society for General Microbiology.